Profound Medical to Present at Lake Street’s BIG10 Growth Conference
Event summary
- Profound Medical to participate in Lake Street’s 10th Annual Best Ideas Growth Conference on September 10, 2026, in New York City.
- Event will consist of one-on-one investor meetings; no webcast available.
- Profound Medical specializes in interventional MRI (iMRI) procedures, with flagship products TULSA-PRO and Sonalleve.
- TULSA-PRO is FDA-cleared for prostate ablation, while Sonalleve is approved for bone metastases and gynecologic conditions.
The big picture
Profound Medical’s participation in the Lake Street conference underscores its focus on engaging with investors to highlight its innovative MRI-guided therapy solutions. The company’s strategic positioning in the medical device sector, particularly in prostate and gynecologic care, aligns with the growing demand for minimally invasive, precision treatments. The event provides a platform to discuss the company’s commercial-stage products and potential for expansion in key global markets.
What we're watching
- Investor Sentiment
- How the one-on-one investor meetings will impact Profound Medical’s stock performance and market perception.
- Product Expansion
- The pace at which Profound Medical can expand clinical applications for Sonalleve, including non-invasive ablation of abdominal cancers.
- Regulatory Approvals
- Whether Profound Medical can secure additional regulatory clearances to broaden its global market reach.
Related topics